Cat Hall, VP of Product Strategy at endpoint will be speaking on “Innovative Trial Design during COVID-19” on Tuesday, Nov. 3 at 10:45 GMT (05:45 EST) at Clinical Trials Europe.
What You’ll Learn:
Cat started her career as an academic scientist in Molecular and Cellular before finishing her MBA and transitioning into Pharmaceutical Supply Chain Management. During her career, Cat developed notable expertise not only in clinical supplies but also in training development, process improvement, managing partnerships, and the design and implementation of technologies such as IRT. Catherine is most well-known for bringing a focus to bridging the GMP/GCP gap by bringing supply chain customer service through the last mile to patients. Cat joined endpoint in 2019 as VP of Product Strategy to help continue to bring the customer voice forward into shaping the future of IRT.
Clinical Trials Europe Virtual
2-4 November 2020
Call us from within the United States:
Calling from outside the United States?